OpenEvidence Confirms It Has Raised An Additional $250 Million At A $15 Billion Valuation
Direct Source Verification:
This story is aggregated from Forbes (forbes.com). Full reporting rights and copyright belong to the primary publisher.
OpenEvidence is a leading AI driven clinical decision support tool.
For complete coverage, context, and related multimedia, visit the original reporting by Forbes via the source link below.
Original Source
https://www.forbes.com/sites/saibala/2026/09/30/openevidence-confirms-it-has-raised-an-additional-250-million-at-a-15-billion-valuation/
